No Data
No Data
BioCryst Pharmaceuticals(BCRX.US) Director Buys US$49,995.96 in Common Stock
$BioCryst Pharmaceuticals(BCRX.US)$ Director LEVIN ALAN G purchased 7,861 shares of common stock on May 30, 2024 at an average price of $6.36 for a total value of $49,995.96.Source: Announcement What
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX): When Will It Breakeven?
We feel now is a pretty good time to analyse BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) business as it appears the company may be on the cusp of a considerable accomplishment. BioCryst Pharmaceu
BioCryst Pharmaceuticals(BCRX.US) Director Buys US$16,000 in Common Stock
$BioCryst Pharmaceuticals(BCRX.US)$ Director ASELAGE STEVE purchased 2,500 shares of common stock on May 24, 2024 at an average price of $6.4 for a total value of $16,000.Source: Announcement What is
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Is Expected To Breakeven In The Near Future
BioCryst Pharmaceuticals(BCRX.US) Director Buys US$31,900 in Common Stock
$BioCryst Pharmaceuticals(BCRX.US)$ Director Hutson Nancy J purchased 5,000 shares of common stock on May 20, 2024 at an average price of $6.38 for a total value of $31,900.Source: Announcement What i
BioCryst Pharmaceuticals(BCRX.US) Director Buys US$93,750 in Common Stock
$BioCryst Pharmaceuticals(BCRX.US)$ Director MILANO VINCENT purchased 15,000 shares of common stock on May 20, 2024 at an average price of $6.25 for a total value of $93,750.Source: Announcement What
No Data